Synergistic Diarylalkane-Based Systems for Personalized Skin Treatment and Monitoring
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates diarylalkane-based compositions with distinct technologies such as AI, IoT, blockchain, and nanomaterials to create novel systems for personalized skin treatment, real-time monitoring, and secure authentication, thereby revolutionizing the skincare industry.
Background and Problem Solved
The original patent disclosed diarylalkane-based compositions for treating skin pigmentation due to inflammatory conditions. However, it lacked the capabilities for personalized treatment, real-time monitoring, and secure authentication, which are essential for effective skin treatment. The present inventive concept addresses these limitations by combining diarylalkane-based compositions with advanced technologies to provide a comprehensive solution for skin treatment and monitoring.
Detailed Description of the Inventive Concept
The inventive concept encompasses various systems and methods that integrate diarylalkane-based compositions with AI-driven skin analysis modules, IoT-enabled sensors, blockchain-based platforms, and nanomaterials. For instance, a system for personalized skin treatment comprises a diarylalkane-based composition and an AI-driven skin analysis module that determines optimal treatment regimens based on individual skin characteristics. Another embodiment includes a method for real-time monitoring of skin pigmentation using IoT-enabled sensors and a diarylalkane-based composition for treating skin pigmentation due to inflammatory conditions. Additionally, a blockchain-based platform can be used for secure tracking and authentication of diarylalkane-based compositions used in skin treatment, ensuring transparency and trust in the skincare industry.
Novelty and Inventive Step
The present inventive concept is novel and non-obvious in its integration of diarylalkane-based compositions with distinct technologies, providing a synergistic effect that enhances the efficacy and convenience of skin treatment and monitoring. The inventive concept's novelty lies in its ability to provide personalized treatment, real-time monitoring, and secure authentication, which are not achievable by the original patent alone.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of other advanced technologies, such as machine learning algorithms, augmented reality, or biometrics, to further enhance the capabilities of the systems and methods. Variations of the inventive concept may also include the development of new diarylalkane-based compositions with improved efficacy or stability, or the integration of the inventive concept with existing skincare products or services.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the skincare industry, where personalized treatment and real-time monitoring are increasingly demanded. The market for skincare products and services is projected to grow significantly in the coming years, driven by the increasing awareness of skin health and the demand for effective and convenient solutions. The inventive concept's ability to provide a comprehensive solution for skin treatment and monitoring positions it for success in this growing market.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K8/347 |
| A | A61 | A61K8/31 |
| A | A61 | A61K8/4973 |
| A | A61 | A61K8/9789 |
| A | A61 | A61K8/9794 |
| A | A61 | A61K31/015 |
| A | A61 | A61K31/05 |
| A | A61 | A61K31/085 |
| A | A61 | A61K31/09 |
| A | A61 | A61K31/357 |
| A | A61 | A61K31/40 |
| A | A61 | A61K31/704 |
| A | A61 | A61Q19/02 |
| C | C07 | C07C39/15 |
| C | C07 | C07C39/367 |
| C | C07 | C07C41/26 |
| C | C07 | C07C41/32 |
| C | C07 | C07C43/23 |
| C | C07 | C07C45/673 |
| C | C07 | C07C49/835 |
| C | C07 | C07C215/74 |
| C | C07 | C07D321/12 |
| A | A61 | A61K2800/782 |
| Y | Y02 | Y02A50/30 |
Original Patent Information
| Patent Number | US 11,857,657 |
|---|---|
| Title | Diarylalkanes as potent inhibitors of binuclear enzymes |
| Assignee(s) | Unigen, Inc. |